Canada's drug bill near C$30B in 2008

19 April 2009

Canada's total drug spending is estimated to have reached C$29.8 billion ($24.31 billion) in 2008, according to the Canadian Institute for Health  Information, a rise of 8.3% versus the previous year. Prescribed  medicine costs, accounting for 84% of the total drug bill, rose 9% vs  only 4.6% for over-the-counter products.

Michael Hunt, the manager of pharmaceutical programs at the CIHI, said:  "over the last 20 years, drugs have consistently remained one of the  major cost drivers in health care. Spending on pharmaceuticals has more  than doubled over the past 10 years, outpacing growth in health spending  by hospitals, physicians and other health professionals."

The aggregate figures hide key differences in the performance of  various areas of Canadian health care. For example, the biggest increase  in spending on prescription medicines has been in the private sector, up  11% in 2008 to C$14.0 billion, which represents over 55% of the  country's Rx expenditure. By contrast, public-sector spending on the  same categories of drug was up 6.7%, reaching C$11.2 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight